Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.

Smith CT, Dang LC, Cowan RL, Kessler RM, Zald DH
Neuropharmacology. 2016 108: 394-402

PMID: 27174408 · PMCID: PMC4912942 · DOI:10.1016/j.neuropharm.2016.05.004

Subjective responses to psychostimulants vary, the basis of which is poorly understood, especially in relation to possible cortical contributions. Here, we tested for relationships between participants' positive subjective responses to oral d-amphetamine (dAMPH) versus placebo and variability in striatal and extrastriatal dopamine (DA) receptor availability and release, measured via positron emission tomography (PET) with the radiotracer (18)F-fallypride. Analyses focused on 35 healthy adult participants showing positive subjective effects to dAMPH measured via the Drug Effects Questionnaire (DEQ) Feel, Like, High, and Want More subscales (Responders), and were repeated after inclusion of 11 subjects who lacked subjective responses. Associations between peak DEQ subscale ratings and both baseline (18)F-fallypride binding potential (BPnd; an index of D2/D3 receptor availability) and the percentage change in BPnd post dAMPH (%ΔBPnd; a measure of DA release) were assessed. Baseline BPnd in ventromedial prefrontal cortex (vmPFC) predicted the peak level of High reported following dAMPH. Furthermore, %ΔBPnd in vmPFC positively correlated with DEQ Want More ratings. DEQ Want More was also positively correlated with %ΔBPnd in right ventral striatum and left insula. This work indicates that characteristics of DA functioning in vmPFC, a cortical area implicated in subjective valuation, are associated with both subjective high and incentive (wanting) responses. The observation that insula %ΔBPnd was associated with drug wanting converges with evidence suggesting its role in drug craving. These findings highlight the importance of variability in DA signaling in specific paralimbic cortical regions in dAMPH's subjective response, which may confer risk for abusing psychostimulants.

Copyright © 2016 Elsevier Ltd. All rights reserved.

MeSH Terms (14)

Administration, Oral Adolescent Adult Central Nervous System Stimulants Corpus Striatum Dextroamphetamine Dopamine Humans Male Positron-Emission Tomography Prefrontal Cortex Receptors, Dopamine D2 Signal Transduction Young Adult

Connections (2)

This publication is referenced by other Labnodes entities: